Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii

被引:8
|
作者
Ghaffari, Ali Dalir [1 ]
Dalimi, Abdolhossein [1 ]
Ghaffarifar, Fatemeh [1 ]
Pirestani, Majid [1 ]
机构
[1] Tarbiat Modares Univ, Fac Med Sci, Dept Parasitol, PD Box 14115-331, Tehran, Iran
基金
美国国家科学基金会;
关键词
Toxoplasma gondii; Epitope mapping; Computational biology; Vaccines; B-CELL EPITOPES; PREDICTION; IDENTIFICATION; APICOMPLEXA; RESISTANCE; ORGANELLES; INVASION;
D O I
10.7774/cevr.2020.9.2.81
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: Toxoplasma gondii is an opportunistic parasite infecting all warm-blooded animals including humans. The dense granule antigens (GRAs) play an important role in parasite survival and virulence and in forming the parasitophorous vacuole. Identification of protein characteristics increases our knowledge about them and leads to develop the vaccine and diagnostic studies. Materials and Methods: This paper gave a comprehensive definition of the important aspects of GRA12 protein, including physico-chemical features, a transmembrane domain, subcellular position, secondary and tertiary structure, potential epitopes of B-cells and T-cells, and other important features of this protein using different and reliable bioinformatics methods to determine potential epitopes for designing of a high-efficient vaccine. Results: The findings showed that GRA12 protein had 53 potential post-translational modification sites. Also, only one transmembrane domain was recognized for this protein. The secondary structure of GRA12 protein comprises 35.55% alpha-helix, 19.50% extended strand, and 44.95% random coil. Moreover, several potential B- and T-cell epitopes were identified for GRA12. Based on the results of the Ramachandran plot, 79.26% of amino acid residues were located in favored, 11.85% in allowed and 8.89% in outlier regions. Furthermore, the results of the antigenicity and allergenicity assessment noted that GRA12 is immunogenic and non-allergenic. Conclusion: This research provided important basic and conceptual data on GRA12 to develop an effective vaccine against acute and chronic toxoplasmosis for further in vivo investigations. More studies are required on vaccine development using the GRA12 alone or combined with other antigens in the future.
引用
收藏
页码:81 / 96
页数:16
相关论文
共 20 条
  • [1] Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii
    Foroutan, Masoud
    Ghaffarifar, Fatemeh
    Sharifi, Zohreh
    Dalimi, Abdolhosein
    Pirestani, Majid
    INFECTION GENETICS AND EVOLUTION, 2018, 62 : 193 - 204
  • [2] Toxoplasma gondii ROP38 protein: Bioinformatics analysis for vaccine design improvement against toxoplasmosis
    Nosrati, MohammadReza Chaechi
    Ghasemi, Ezatollah
    Shams, Morteza
    Shamsinia, Sadegh
    Yousefi, Ali
    Nourmohammadi, Hassan
    Javanmardi, Erfan
    Kordi, Bahareh
    Majidiani, Hamidreza
    Ghaffari, Ali Dalir
    Shakarami, Farzaneh
    MICROBIAL PATHOGENESIS, 2020, 149
  • [3] Analysis of Apical Membrane Antigen (AMA)-1 characteristics using bioinformatics tools in order to vaccine design against Plasmodium vivax
    Jahangiri, Farhad
    Jalallou, Nahid
    Ebrahimi, Mansour
    INFECTION GENETICS AND EVOLUTION, 2019, 71 : 224 - 231
  • [4] Novel roles of dense granule protein 12 (GRA12) in Toxoplasma gondii infection
    Wang, Jin-Lei
    Bai, Meng-Jie
    Elsheikha, Hany M.
    Liang, Qin-Li
    Li, Ting-Ting
    Cao, Xue-Zhen
    Zhu, Xing-Quan
    FASEB JOURNAL, 2020, 34 (02) : 3165 - 3178
  • [5] Structural predication and antigenic analysis of ROP16 protein utilizing immunoinformatics methods in order to identification of a vaccine against Toxoplasma gondii: An in silico approach
    Ghaffari, Ali Dalir
    Dalimi, Abdolhossein
    Ghaffarifar, Fatemeh
    Pirestani, Majid
    MICROBIAL PATHOGENESIS, 2020, 142
  • [6] Computational probing of Toxoplasma gondii major surface antigen 1 (SAG1) for enhanced vaccine design against toxoplasmosis
    Majidiani, Hamidreza
    Dalimi, Abdolhossein
    Ghaffarifar, Fatemeh
    Pirestani, Majid
    Ghaffari, Ali Dalir
    MICROBIAL PATHOGENESIS, 2020, 147
  • [7] Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7
    Neudeck, A
    Stachelhaus, S
    Nischik, N
    Striepen, B
    Reichmann, G
    Fischer, HG
    MICROBES AND INFECTION, 2002, 4 (06) : 581 - 590
  • [8] Development and evaluation of indirect enzyme-linked immunosorbent assay using recombinant dense granule antigen 7 protein for the detection of Toxoplasma gondii infection in cats in Thailand
    Suwan, Eukote
    Chalermwong, Piangjai
    Rucksaken, Rucksak
    Sussadee, Metita
    Kaewmongkol, Sarawan
    Udonsom, Ruenruetai
    Jittapalapong, Sathaporn
    Mangkit, Bandid
    VETERINARY WORLD, 2022, 15 (03) : 602 - 610
  • [9] A recombinant protein vaccine encoding Toxoplasma gondii Cyst wall 2 (dense granule protein 47) provides partial protection against acute and chronic T. gondii infection in BALB/c mice
    Tian, Xiaowei
    Wang, Meng
    Xie, Tong
    Wan, Guangmin
    Sun, Hanqi
    Mei, Xuefang
    Zhang, Zhenchao
    Li, Xiangrui
    Wang, Shuai
    ACTA TROPICA, 2022, 232
  • [10] Protective efficacy of recombinant Toxoplasma gondii dense granule protein 15 against toxoplasmosis in C57BL/6 mice
    Hasan, Tanjila
    Shimoda, Naomi
    Nakamura, Shu
    Fox, Barbara A.
    Bzik, David J.
    Ushio-Watanabe, Nanako
    Nishikawa, Yoshifumi
    VACCINE, 2024, 42 (09) : 2299 - 2309